Quarterly report pursuant to Section 13 or 15(d)

Note Receivable - Moleculin LLC (Details Textual)

v3.5.0.1
Note Receivable - Moleculin LLC (Details Textual) - USD ($)
Apr. 05, 2016
Jan. 08, 2016
May 02, 2016
Mar. 31, 2016
Dec. 31, 2015
Notes, Loans and Financing Receivable, Net, Current, Total       $ 30,000 $ 0
Moleculin LLC [Member]          
Line of Credit Facility, Maximum Borrowing Capacity   $ 50,000      
Line of Credit Facility, Interest Rate During Period   8.00%      
Line of Credit Facility, Late Charge Fee Percentage   5.00%      
Notes, Loans and Financing Receivable, Net, Current, Total       $ 30,000  
Moleculin LLC [Member] | Subsequent Event [Member]          
Payments to Fund Notes Receivable to Related Parties $ 27,822        
Financing Receivable, Net, Total 57,822        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables     $ 57,822    
Moleculin LLC [Member] | Subsequent Event [Member] | Maximum [Member]          
Line of Credit Facility, Maximum Borrowing Capacity 60,000        
Moleculin LLC [Member] | Subsequent Event [Member] | Minimum [Member]          
Line of Credit Facility, Maximum Borrowing Capacity $ 50,000